The 12th International Rotavirus Symposium was held 7-9 September, 2016, in Melbourne, Australia. It brought together more than 350 interested stakeholders from more 50 countries to provide an update on new data and relevant research that will inform public health agendas related to prevention of rotavirus gastroenteritis.

Main Session Topics

Participants discussed the latest results of trials of new rotavirus vaccines in developing country settings, issues in vaccine policy and introduction, and early post-marketing data on vaccine impact and safety. Sessions included:

  • Update on rotavirus vaccines
  • Early experiences with introduction of new rotavirus vaccines
  • Epidemiology and burden of rotavirus disease
  • The pipeline for rotavirus vaccines
  • The next steps for rotavirus vaccines

Presentations from the symposium can be found here.

A blog on the symposium can be found here.



 


The Program Committee would like to thank the following for their support toward the organization and success of this meeting:

  • Bill & Melinda Gates Foundation
  • Bharat Biotech
  • US Centers for Disease Control and Prevention
  • Fogarty International Center, US National Institutes of Health
  • GlaxoSmithKline
  • Merck Pharmaceuticals
  • Murdoch Children’s Research Institute, University of Melbourne
  • PATH
  • ROTA Council
  • Sabin Vaccine Institute
  • Serum Institute of India, Ltd.
  • World Health Organization

 

Event Date: 
Wednesday, September 7, 2016 to Friday, September 9, 2016
Event Location: 
Melbourne, Australia
Event Email Contact: